ArticleGenome research2012
An emerging toolkit for targeted cancer therapies.
Article in Genome research, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Review
- Review
- Amplicon-Based NGS Panels for Actionable Cancer Target Identification in Follicular Cell-Derived Thyroid Neoplasia.Frontiers in endocrinology · 2020Article
- The many faces of mathematical modelling in oncology.The British journal of radiology · 2019Review
- Targeting therapeutic liabilities engendered by PIK3R1 mutations for cancer treatment.Pharmacogenomics · 2016Review
- Leaving the lysosome behind: novel developments in autophagy inhibition.Future medicinal chemistry · 2016Review
- [Mutational tumor profiles beyond organ and tissue specificity: implications for diagnostics and clinical study design].Der Pathologe · 2014Review
- Cancer Systems Biology: a peek into the future of patient care?Nature reviews. Clinical oncology · 2014Review
- Overcoming implementation challenges of personalized cancer therapy.Nature reviews. Clinical oncology · 2012Review
- Utility of Precision Oncology Using Cancer Genomic Profiling for Head and Neck Malignancies.In vivo (Athens, Greece)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.